ANIKA THERAPEUTICS INC (ANIK) is a publicly traded company in the Unknown sector. Across all available filings, 34 corporate insiders have executed 603 transactions totaling $94.2M, demonstrating a bearish sentiment with -$92.7M in net insider flow. The most recent transaction on Jul 9, 2024 involved a transaction of 5,771 shares valued at $0.
No significant insider buying has been recorded for ANIK in the recent period.
No significant insider selling has been recorded for ANIK in the recent period.
Based on recent SEC filings, insider sentiment for ANIK is bearish with an Insider Alignment Score of 1/100 and a net flow of -$92.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at ANIKA THERAPEUTICS INC (ANIK) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 34 insiders are actively trading ANIK stock, having executed 603 transactions in the past 90 days. The most active insider is Charles H. Sherwood (Executive), who has made 211 transactions totaling $36.6M.
Get notified when executives and directors at ANIK file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 9, 2024 | H. Capper Joseph | Executive | Award | 5,771 | $N/A | $0 | |
| Jul 9, 2024 | L. Conley Sheryl | Executive | Award | 5,771 | $N/A | $0 | |
| Jul 9, 2024 | P. Fischetti Gary | Executive | Award | 5,771 | $N/A | $0 | |
| Jul 9, 2024 | B. Henneman John III | Executive | Award | 5,771 | $N/A | $0 | |
| Jul 9, 2024 | R. Jellison William | Executive | Award | 5,771 | $N/A | $0 | |
| Jul 9, 2024 | R. Larsen Glenn | Executive | Award | 5,771 | $N/A | $0 | |
| Jul 9, 2024 | Richard Stephen | Executive | Award | 5,771 | $N/A | $0 | |
| Jul 9, 2024 | L. N. Vogt Susan | Executive | Award | 5,771 | $N/A | $0 | |
| Jun 3, 2024 | H. Capper Joseph | Executive | Award | 468 | $N/A | $0 | |
| Jun 3, 2024 | R. Jellison William | Executive | Award | 468 | $N/A | $0 | |
| Mar 11, 2024 | L. Levitz Michael | Executive | Payment | 2,610 | $25.79 | $67.3K | |
| Mar 11, 2024 | L. Levitz Michael | Executive | Option Exercise | 8,888 | $N/A | $0 | |
| Mar 11, 2024 | L. Levitz Michael | Executive | Payment | 1,725 | $25.42 | $43.8K | |
| Mar 11, 2024 | L. Levitz Michael | Executive | Option Exercise | 5,875 | $N/A | $0 | |
| Mar 11, 2024 | L. Levitz Michael | Executive | Payment | 1,303 | $25.42 | $33.1K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 282 | $93.4M | 81.9% |
Payment(F) | 52 | $12.5M | 11.0% |
Exercise(M) | 112 | $6.0M | 5.3% |
Award(A) | 128 | $1.3M | 1.2% |
Purchase(P) | 21 | $758.3K | 0.7% |
Gift(G) | 4 | $0 | 0.0% |
Other(J) | 4 | $0 | 0.0% |
Insider selling pressure at ANIKA THERAPEUTICS INC has increased, with 34 insiders executing 603 transactions across all time. Total sales of $93.4M significantly outpace purchases of $758.3K, resulting in a net outflow of $92.7M. This selling activity appears largely discretionary, which may warrant closer attention from investors.